PL2121919T3 - Zmutowane receptory związane z białkiem G i sposoby ich wyboru - Google Patents

Zmutowane receptory związane z białkiem G i sposoby ich wyboru

Info

Publication number
PL2121919T3
PL2121919T3 PL08718823T PL08718823T PL2121919T3 PL 2121919 T3 PL2121919 T3 PL 2121919T3 PL 08718823 T PL08718823 T PL 08718823T PL 08718823 T PL08718823 T PL 08718823T PL 2121919 T3 PL2121919 T3 PL 2121919T3
Authority
PL
Poland
Prior art keywords
selecting
gpcr
ligand
mutant
protein coupled
Prior art date
Application number
PL08718823T
Other languages
English (en)
Polish (pl)
Inventor
Richard Henderson
Christopher Gordon Tate
Francesca Magnani
Maria Josefa Serrano-Vega
Yoko Shibata
Anthony Johannes Warne
Malcolm Peter Weir
Original Assignee
Heptares Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0705450A external-priority patent/GB0705450D0/en
Priority claimed from GB0724052A external-priority patent/GB0724052D0/en
Application filed by Heptares Therapeutics Ltd filed Critical Heptares Therapeutics Ltd
Publication of PL2121919T3 publication Critical patent/PL2121919T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
PL08718823T 2007-03-22 2008-03-20 Zmutowane receptory związane z białkiem G i sposoby ich wyboru PL2121919T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0705450A GB0705450D0 (en) 2007-03-22 2007-03-22 Mutant proteins and method for selecting them
GB0724052A GB0724052D0 (en) 2007-12-08 2007-12-08 Mutant proteins and methods for selecting them
EP08718823A EP2121919B1 (en) 2007-03-22 2008-03-20 Mutant g-protein coupled receptors and methods for selecting them
PCT/GB2008/000986 WO2008114020A2 (en) 2007-03-22 2008-03-20 Mutant g-protein coupled receptors and methods for selecting them

Publications (1)

Publication Number Publication Date
PL2121919T3 true PL2121919T3 (pl) 2012-07-31

Family

ID=39386585

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08718823T PL2121919T3 (pl) 2007-03-22 2008-03-20 Zmutowane receptory związane z białkiem G i sposoby ich wyboru

Country Status (14)

Country Link
US (7) US8785135B2 (enExample)
EP (4) EP2121919B1 (enExample)
JP (6) JP4842400B2 (enExample)
CN (2) CN101688203B (enExample)
AT (1) ATE544854T1 (enExample)
AU (1) AU2008228085B2 (enExample)
CA (1) CA2681415C (enExample)
DK (1) DK2121919T3 (enExample)
ES (2) ES3008359T3 (enExample)
GB (4) GB2456235B8 (enExample)
HR (1) HRP20120336T1 (enExample)
PL (1) PL2121919T3 (enExample)
PT (1) PT2121919E (enExample)
WO (1) WO2008114020A2 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101688203B (zh) * 2007-03-22 2013-12-11 赫普泰雅治疗有限公司 突变的g蛋白偶联受体及其选择方法
GB0724051D0 (en) * 2007-12-08 2008-01-16 Medical Res Council Mutant proteins and methods for producing them
GB0724860D0 (en) * 2007-12-20 2008-01-30 Heptares Therapeutics Ltd Screening
GB0802474D0 (en) 2008-02-11 2008-03-19 Heptares Therapeutics Ltd Mutant proteins and methods for selecting them
US20110112037A1 (en) * 2008-03-05 2011-05-12 Heptares Therapeutics Limited BioPark Crystal structure
GB0910725D0 (en) 2009-06-22 2009-08-05 Heptares Therapeutics Ltd Mutant proteins and methods for producing them
GB201014715D0 (en) 2010-09-06 2010-10-20 Vib Vzw Nanobodies stabilizing functional conformational states of GPCRS
EP3333185A1 (en) 2010-08-20 2018-06-13 Heptares Therapeutics Limited Mutant gpcrs
US20140031525A1 (en) * 2011-01-21 2014-01-30 Heptares Therapeutics Limited Mutant g-protein coupled receptor proteins and methods for producing them
CA2827187C (en) 2011-02-23 2019-01-08 Massachusetts Institute Of Technology Water soluble membrane proteins and methods for the preparation and use thereof
WO2012120315A2 (en) 2011-03-10 2012-09-13 Heptares Therapeutics Limited Mutant proteins and methods for producing them
CN107739408A (zh) * 2011-08-10 2018-02-27 赫普泰雅治疗有限公司 稳定的蛋白质
ES2676827T3 (es) * 2012-06-01 2018-07-25 Heptares Therapeutics Limited Ensayos
CN105102478A (zh) 2013-01-30 2015-11-25 弗拉芒区生物技术研究所 用于筛选和药物发现目的的新型嵌合多肽
WO2014140586A2 (en) 2013-03-15 2014-09-18 Medical Research Council Mutant proteins and methods for their production
WO2014176524A2 (en) 2013-04-25 2014-10-30 The Trustees Of The University Of Pennsylvania Opioid detection based on high quality graphene transistor arrays and a synthetic mu receptor
WO2014176544A1 (en) * 2013-04-25 2014-10-30 The Trustees Of The University Of Pennsylvania Water soluble g-protein coupled receptor
CN105593240B (zh) * 2013-06-11 2024-05-31 保罗·谢勒学院 用于以单氨基酸分辨率确定可突变配体-gpcr结合的方法以及突变配体和gpcr对
US10373702B2 (en) 2014-03-27 2019-08-06 Massachusetts Institute Of Technology Water-soluble trans-membrane proteins and methods for the preparation and use thereof
CN104151401A (zh) * 2014-06-05 2014-11-19 维亚生物科技(上海)有限公司 融合表达离子通道蛋白及运输蛋白的方法及其使用的蛋白片断
GB2527286A (en) 2014-06-11 2015-12-23 Rsr Ltd Glycoprotein hormone receptor mutations
WO2016070022A1 (en) 2014-10-31 2016-05-06 Abilita Bio, Inc. Modified membrane spanning proteins and methods for the preparation and use thereof
WO2017022696A1 (ja) 2015-07-31 2017-02-09 国立研究開発法人理化学研究所 膜タンパク質の製造方法およびその利用
GB201601690D0 (en) 2016-01-29 2016-03-16 Heptares Therapeutics Ltd G proteins
EP3205450A1 (de) * 2016-02-09 2017-08-16 Hermes Schleifkörper GmbH Verfahren zur herstellung eines keramischen formkörpers
US10845367B2 (en) 2016-05-04 2020-11-24 Abilita Bio, Inc. Modified multispanning membrane polypeptides and methods of use thereof to screen therapeutic agents
CN109553687B (zh) * 2017-09-27 2021-07-06 北京大学 基于g蛋白偶联受体构建的荧光探针
US12123814B1 (en) * 2019-06-14 2024-10-22 Pierce Biotechnology, Inc. G- protein coupled receptor extraction formulations
AU2021409906A1 (en) 2020-12-23 2023-06-15 Regeneron Pharmaceuticals, Inc. Methods for obtaining antibodies that bind transmembrane proteins and cells that produce the same
CN114038498B (zh) * 2022-01-06 2022-03-18 北京晶泰科技有限公司 Gpcr的热稳定性突变预测方法、结构筛选方法及其装置

Family Cites Families (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
ATE189526T1 (de) 1988-10-28 2000-02-15 Genentech Inc Verfahren zum nachweis von aktiven domänen und aminosäureresten in polypeptiden und hormonvarianten
US6780613B1 (en) * 1988-10-28 2004-08-24 Genentech, Inc. Growth hormone variants
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
AU665190B2 (en) 1990-07-10 1995-12-21 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
WO1992009690A2 (en) 1990-12-03 1992-06-11 Genentech, Inc. Enrichment method for variant proteins with altered binding properties
ATE439435T1 (de) 1991-03-01 2009-08-15 Dyax Corp Chimäres protein mit mikroprotein mit zwei oder mehr disulfidbindungen und ausgestaltungen davon
JP3147916B2 (ja) * 1991-03-08 2001-03-19 森永製菓株式会社 体外免疫方法
DE69233750D1 (de) 1991-04-10 2009-01-02 Scripps Research Inst Bibliotheken heterodimerer Rezeptoren mittels Phagemiden
DE4122599C2 (de) 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
US20030036092A1 (en) * 1991-11-15 2003-02-20 Board Of Regents, The University Of Texas System Directed evolution of enzymes and antibodies
JPH08500967A (ja) * 1992-06-12 1996-02-06 ガーヴァン インスティチュート オブ メディカル リサーチ ヒトＡ１，Ａ２ａおよびＡ２ｂアデノシン受容体をエンコードするＤＮＡ配列
US5585277A (en) * 1993-06-21 1996-12-17 Scriptgen Pharmaceuticals, Inc. Screening method for identifying ligands for target proteins
JPH10500951A (ja) 1994-05-23 1998-01-27 スミスクライン・ビーチャム・コーポレイション コードされた組合せライブラリー
US20020028443A1 (en) * 1999-09-27 2002-03-07 Jay M. Short Method of dna shuffling with polynucleotides produced by blocking or interrupting a synthesis or amplification process
AU2020497A (en) 1996-03-27 1997-10-17 Susan R. George Receptor and transporter antagonists
AU2728297A (en) * 1996-04-15 1997-11-07 Board Of Trustees Of The Leland Stanford Junior University Soluble 7-transmembrane domain G-protein-coupled receptor compositions and me thods
US6153410A (en) * 1997-03-25 2000-11-28 California Institute Of Technology Recombination of polynucleotide sequences using random or defined primers
US6555339B1 (en) 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
CA2323638A1 (en) * 1998-04-03 1999-10-14 Phylos, Inc. Addressable protein arrays
JP2002510790A (ja) 1998-04-06 2002-04-09 ブンセン ラッシュ ラボラトリーズ インコーポレーテッド 指向的進化バイオセンサ
US6692696B1 (en) 1998-06-18 2004-02-17 ARETé ASSOCIATES Biosensor
US7094593B1 (en) * 1998-09-01 2006-08-22 Basf Aktiengesellschaft Method for improving the function of heterologous G protein-coupled receptors
WO2000012704A2 (en) * 1998-09-01 2000-03-09 Basf Aktiengesellschaft Enhanced functional expression of g protein-coupled receptors
AU4847600A (en) 1999-05-14 2000-12-05 Repliscent, Inc. G-protein coupled receptor (gpcr) based biosensors and sense replication systems
IL149569A0 (en) * 1999-11-17 2002-11-10 Arena Pharm Inc Endogenous and non-endogenous versions of human g protein-coupled receptors
AU2001243145A1 (en) 2000-02-09 2001-08-20 Human Genome Sciences, Inc. Human g-protein chemokine receptor (ccr5) hdgnr10
US7678539B2 (en) 2000-08-10 2010-03-16 Corning Incorporated Arrays of biological membranes and methods and use thereof
AU2001286945A1 (en) * 2000-08-30 2002-03-13 John Hopkins University School Of Medicine Identification of activated receptors and ion channels
US6448377B1 (en) * 2000-09-27 2002-09-10 The Board Of Trustees Of The Leland Stanford Junior University Modified G protein sunbunits
CA2425149A1 (en) * 2000-10-26 2002-08-01 New England Medical Center Hospitals, Inc. Constitutively active, hypersensitive, and nonfunctional receptors as novel therapeutic agents
US20030232331A1 (en) * 2000-12-05 2003-12-18 Casman Stacie J. Novel proteins and nucleic acids encoding same
AU2002303091B2 (en) 2001-02-14 2006-11-09 Amgen, Inc. G-protein coupled receptor molecules and uses thereof
CN1516706A (zh) 2001-02-26 2004-07-28 阿伦纳药品公司 人g蛋白偶联受体的内源性和非内源性形式
US7208279B2 (en) * 2001-03-14 2007-04-24 Caden Biosciences, Inc. Method for identifying inhibitors of G protein coupled receptor signaling
US7294472B2 (en) 2001-03-14 2007-11-13 Caden Biosciences Method for identifying modulators of G protein coupled receptor signaling
JPWO2002079784A1 (ja) 2001-03-30 2004-07-22 サントリー株式会社 Ｇ蛋白質結合型レセプターの構造モデルおよび当該構造モデルを用いたｇ蛋白質結合型レセプターに結合するリガンドの設計方法
US20030129649A1 (en) * 2001-04-24 2003-07-10 Kobilka Brian K. Conformational assays to detect binding to G protein-coupled receptors
US20050009204A1 (en) 2003-07-11 2005-01-13 Ye Fang Multiplexed binding assays for receptor arrays
EP1438337B1 (en) 2001-10-25 2006-09-20 Astex Therapeutics Limited Crystals of cytochrome p450 2c9, structures thereof and their use
US7115377B2 (en) * 2001-10-26 2006-10-03 Atto Bioscience, Inc. Cell-based assays for G-protein-coupled receptor-mediated activities
JP2004238384A (ja) * 2002-03-28 2004-08-26 Takeda Chem Ind Ltd 新規スクリーニング方法
EP1491207A4 (en) 2002-03-28 2006-02-08 Takeda Pharmaceutical NEW SCREENING PROCESS
EP1505074A4 (en) 2002-04-24 2005-12-21 Banyu Pharma Co Ltd CONSTITUTATIVE ACTIVE MUTANTS OF A HISTAMINE H3 RECEPTOR AND ITS USES
ATE457728T1 (de) * 2002-05-01 2010-03-15 Vertex Pharma Kristallstruktur des aurora-2 proteins und dessen bindungstaschen
JP2006513702A (ja) * 2002-09-09 2006-04-27 ヌラ インコーポレーティッド Ｇタンパク質共役受容体およびその使用
AU2002951995A0 (en) * 2002-10-11 2002-10-31 Alchemia Limited Classes of compounds that interact with gpcrs
US20040096914A1 (en) 2002-11-20 2004-05-20 Ye Fang Substrates with stable surface chemistry for biological membrane arrays and methods for fabricating thereof
EP1625159B1 (en) * 2003-05-20 2011-03-02 The University Court Of The University Of Glasgow Materials and methods relating to g-protein coupled receptor oligomers
US7745161B2 (en) * 2003-12-19 2010-06-29 Palo Alto Research Center Incorporated Amplification of enzymatic reactions for use with an enthalpy array
US20050287121A1 (en) * 2004-05-12 2005-12-29 Merchiers Pascal G Methods, compositions and compound assays for inhibiting amyloid-beta protein production
WO2005121755A1 (en) 2004-06-14 2005-12-22 Commonwealth Scientific And Industrial Research Organisation Cell free g-protein coupled receptor and ligand assay
US20060188964A1 (en) 2004-07-28 2006-08-24 Filippo Mancia Processing for producing and crystallizing G-protein coupled receptors
JP2006340717A (ja) * 2005-05-11 2006-12-21 Sekisui Chem Co Ltd Ｇタンパク質共役型受容体に対する結合性評価方法及び評価用組成物、融合タンパク質、並びに、遺伝子
FR2890174B1 (fr) 2005-08-30 2009-04-24 Cis Bio Internat Sa Procede pour la mise en evidence d'un processus biologique par mesure d'un fret
US20070154947A1 (en) * 2005-08-31 2007-07-05 The Trustees Of Princeton University Chemical biodiscriminator
WO2007097820A2 (en) * 2005-11-18 2007-08-30 The Ohio State University Research Foundation Viral gene products and methods for vaccination to prevent viral associated diseases
US7495024B2 (en) * 2006-08-07 2009-02-24 Via Pharmaceuticals, Inc. Phenylalkyl N-hydroxyureas for combating atherosclerotic plaque
CN101688203B (zh) 2007-03-22 2013-12-11 赫普泰雅治疗有限公司 突变的g蛋白偶联受体及其选择方法
WO2009051769A1 (en) 2007-10-17 2009-04-23 The Board Of Trustees Of The Leland Stanford Junior University Method and composition for crystallizing g protein-coupled receptors
US8252899B2 (en) 2007-10-22 2012-08-28 The Scripps Research Institute Methods and compositions for obtaining high-resolution crystals of membrane proteins
GB0724051D0 (en) * 2007-12-08 2008-01-16 Medical Res Council Mutant proteins and methods for producing them
GB0724860D0 (en) * 2007-12-20 2008-01-30 Heptares Therapeutics Ltd Screening
GB0802474D0 (en) * 2008-02-11 2008-03-19 Heptares Therapeutics Ltd Mutant proteins and methods for selecting them
US20110112037A1 (en) * 2008-03-05 2011-05-12 Heptares Therapeutics Limited BioPark Crystal structure
GB0910725D0 (en) * 2009-06-22 2009-08-05 Heptares Therapeutics Ltd Mutant proteins and methods for producing them
EP3333185A1 (en) 2010-08-20 2018-06-13 Heptares Therapeutics Limited Mutant gpcrs
DK2611826T3 (en) 2010-08-30 2017-01-09 Confometrx Inc A method and composition for the crystallization of a family-C-GPCR
US20140031525A1 (en) * 2011-01-21 2014-01-30 Heptares Therapeutics Limited Mutant g-protein coupled receptor proteins and methods for producing them
SG194522A1 (en) 2011-05-13 2013-12-30 Receptos Inc Novel fusion partners for the purpose of crystallizing g-protein coupled receptors
CN107739408A (zh) 2011-08-10 2018-02-27 赫普泰雅治疗有限公司 稳定的蛋白质
EP2617732A1 (en) 2012-01-19 2013-07-24 Vib Vzw Tools and methods for expression of membrane proteins
WO2013142278A1 (en) 2012-03-22 2013-09-26 New York University Plasmodium vivax vaccine compositions
ES2676827T3 (es) 2012-06-01 2018-07-25 Heptares Therapeutics Limited Ensayos
WO2014028644A1 (en) 2012-08-15 2014-02-20 Cyvax, Inc. Methods and compositions for preventing a condition
US20150261911A1 (en) 2014-03-13 2015-09-17 Heptares Therapeutics Limited Crystal structure

Also Published As

Publication number Publication date
US8785135B2 (en) 2014-07-22
CN103641908A (zh) 2014-03-19
WO2008114020A3 (en) 2009-03-19
GB0901111D0 (en) 2009-03-11
EP2386635A3 (en) 2012-02-08
GB2456236B8 (en) 2009-12-09
GB2456235B8 (en) 2009-12-09
GB0805267D0 (en) 2008-04-30
CN101688203A (zh) 2010-03-31
GB2447786A (en) 2008-09-24
ES2381780T3 (es) 2012-05-31
WO2008114020A2 (en) 2008-09-25
US20180086814A1 (en) 2018-03-29
GB2456237B8 (en) 2009-12-09
ES3008359T3 (en) 2025-03-24
JP2014155502A (ja) 2014-08-28
DK2121919T3 (da) 2012-05-21
US20160052991A1 (en) 2016-02-25
EP3926045C0 (en) 2025-01-01
US11673938B2 (en) 2023-06-13
GB2456236B (en) 2009-10-28
JP2018164456A (ja) 2018-10-25
EP2450445A1 (en) 2012-05-09
HRP20120336T1 (hr) 2012-05-31
PT2121919E (pt) 2012-05-17
GB2456237B (en) 2009-10-28
GB2447786C (en) 2011-11-09
JP2021036901A (ja) 2021-03-11
JP7419217B2 (ja) 2024-01-22
EP3926045B1 (en) 2025-01-01
JP6426661B2 (ja) 2018-11-21
AU2008228085B2 (en) 2011-12-08
JP2011224018A (ja) 2011-11-10
CA2681415C (en) 2020-11-03
JP2010521983A (ja) 2010-07-01
EP3926045A1 (en) 2021-12-22
CN101688203B (zh) 2013-12-11
EP2386635A2 (en) 2011-11-16
US20100190188A1 (en) 2010-07-29
GB2456237A (en) 2009-07-15
EP2121919A2 (en) 2009-11-25
GB0901095D0 (en) 2009-03-11
GB2456236A (en) 2009-07-15
US20210061882A1 (en) 2021-03-04
US20190241644A1 (en) 2019-08-08
AU2008228085A1 (en) 2008-09-25
GB2456235A (en) 2009-07-15
GB2447786B (en) 2009-11-11
ATE544854T1 (de) 2012-02-15
US20240052017A1 (en) 2024-02-15
CA2681415A1 (en) 2008-09-25
US20120270230A1 (en) 2012-10-25
WO2008114020A9 (en) 2010-03-11
GB2456235B (en) 2009-10-28
EP2121919B1 (en) 2012-02-08
JP4842400B2 (ja) 2011-12-21
GB0901110D0 (en) 2009-03-11
JP2016187348A (ja) 2016-11-04

Similar Documents

Publication Publication Date Title
PL2121919T3 (pl) Zmutowane receptory związane z białkiem G i sposoby ich wyboru
WO2009081136A3 (en) Screening
WO2009071914A3 (en) Mutant proteins and methods for producing them
WO2007092596A3 (en) Methods and apparatus for predicting the hydrocarbon production of a well location
EP2310844A4 (en) Systems and methods for determining geologic properties using acoustic analysis
WO2010075084A3 (en) User interface tools
EP2068544A4 (en) VOICE MIXING METHOD, MULTIPOINT CONFERENCE SERVER USING THE METHOD AND PROGRAM
NZ592420A (en) Cd86 antagonist multi-target binding proteins
CY1118797T1 (el) Ανταγωνιστες toll-ωδους υποδοχεα 3
WO2008109878A3 (en) Testing device
WO2007120766A3 (en) Erythropoietin receptor agonists
WO2007082144A3 (en) B7-h1 and survivin in cancer
MX2010002994A (es) Dominios de fijacion del ligando de receptores nucleares en forma controlable y metodos que conllevan los mismos.
WO2010040003A3 (en) Human a2a adenosine receptor crystals and uses thereof
WO2011092504A3 (en) Biomarkers for schizophrenia
WO2007115061A3 (en) Bidding for on-line survey placement
WO2008022716A3 (en) Screening method for gpcr ligands
WO2006057988A3 (en) Use of endothelin etb receptor agonists and eta receptor antagonists in tumor imaging
GB0409132D0 (en) Crytographic optimisation for duplicate address detection
WO2007028126A3 (en) Methods and systems for identifying insulin mimetics
WO2009045588A3 (en) Determining seawater conductivity for the compensation of electromagnetics-based survey data
WO2006119497A3 (en) Acetylycholine gated ion channel chaperons and methods of using the same
EP4404201A3 (en) Methods for cancer detection
WO2009155283A3 (en) Radiolabled cyclopamine assay for the smoothened receptor
MY149586A (en) Pcr screening method